MB-5029

N/A

Report date: 2024/05/21 14:15:37

Base Information

Drug NameMB-5029
Drug Alias NameMB5029MB-5029
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed cell death protein 1 modulatorsInterleukin-2 modulators
TargetsProgrammed cell death protein 1Interleukin-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMUSTBIO Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMUSTBIO Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A